Form 4: Neogen Corp Director William T Boehm Reports Acquisition of Restricted Stock Units and Stock Options

Director William T Boehm reports acquiring restricted stock units and stock options in Neogen Corp.

Summary

• On October 24, 2024, William T Boehm, a director of Neogen Corp, reported acquiring 6,075 restricted stock units at a price of $13.58.
• Boehm also acquired 18,653 stock options with an exercise price of $13.58, expiring on October 24, 2031.
• Following these transactions, Boehm beneficially owns 41,137 restricted stock units and 18,653 stock options.
• The options and RSUs vest in equal annual installments over three years from the grant date.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by a company director, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, in their company's stock. This allows the public to monitor insider activity, which can sometimes provide insights into management's view of the company's prospects.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
• Similar filings are required for directors and officers of companies listed on major stock exchanges globally, such as the London Stock Exchange and the Tokyo Stock Exchange, although the specific forms and regulations may vary.
• Companies like Zoetis and IDEXX Laboratories, which operate in similar sectors to Neogen, also have directors and officers who are required to file similar reports when they trade in their company's stock.

Stakeholder Impact

• The acquisition of stock options and restricted stock units by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term performance.

Key Dates